Carregant...
Treatment satisfaction and quality-of-life between type 2 diabetes patients initiating long- vs. intermediate-acting basal insulin therapy in combination with oral hypoglycemic agents – a randomized, prospective, crossover, open clinical trial
BACKGROUND: Pharmacological and clinical differences between insulin glargine and NPH insulin may translate into differences in patient reported outcomes, but existing data are equivocal. METHODS: In this 48-week, open-label, randomized, multi-center, crossover phase IV trial, insulin naïve type 2 d...
Guardat en:
| Publicat a: | Health Qual Life Outcomes |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4459660/ https://ncbi.nlm.nih.gov/pubmed/26055391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12955-015-0279-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|